← Back to Search

Cervical Cancer Screen-and-Treat Strategies for Cervical Cancer (ACCESS Trial)

N/A

Recruiting

Led By Gregory Aarons, PhD

Research Sponsored by University of California, San Diego

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* Women living with HIV

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months after enrollment

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to increase cervical cancer screening & treatment for women living with HIV in Nigeria, improving health & life expectancy.

Who is the study for?

This trial is for women living with HIV in certain low- and middle-income countries. It aims to improve cervical cancer screening and treatment by using existing HIV care infrastructure.

What is being tested?

The ACCESS study compares two approaches: 'Core' strategies versus 'Core+' enhanced strategies, to integrate cervical cancer screen-and-treat services into HIV programs, assessing effectiveness through a cluster randomized design.

What are the potential side effects?

Since the interventions involve implementation strategies rather than medications, traditional side effects are not applicable. However, there may be indirect impacts on patient experience based on how services are delivered.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months after enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months after enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months after enrollment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Reach

Sustainment

Secondary study objectives

CCST Effectiveness

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Core+ Enhanced Implementation StrategiesExperimental Treatment1 Intervention

Includes all of the Core implementation strategies and adds: 5. Community engagement using Health Beginning Initiative Model 6. Smart Cards to facilitate patient engagement

Group II: Core Implementation StrategiesActive Control2 Interventions

Core Implementation Strategies Ongoing consultation Educational meetings Strengthen referral system Prepare patients to be active participants

0 / 1Eligibility criteria met